Hereditary cancer in clinical practice

Keyphrases

Publications

volume 22, number 1, 2024

Hua Yuan, Rong Zhang, Ning Li, Hongwen Yao
Primary fallopian tube cancer followed by primary breast cancer in RAD51C mutation carrier treated with niraparib as first line maintenance therapy: a case report. Hereditary cancer in clinical practice 22 (1) (2024)
Juan Pablo Arango-Ibañez, Luis Gabriel Parra-Lara, Ángela R Zambrano, Lisa Ximena Rodríguez-Rojas
Li-Fraumeni syndrome presenting with de novo TP53 mutation, severe phenotype and advanced paternal age: a case report. Hereditary cancer in clinical practice 22 (1) (2024)
P A Skat-Rørdam, Y Kaya, N Qvist, TvO Hansen, T D Jensen, J G Karstensen, A M Jelsig
Gastrointestinal manifestations in patients with gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a systematic review with analysis of individual patient data. Hereditary cancer in clinical practice 22 (1) (2024)
Lyman Lin, Victoria Beshay, Finlay Macrae
Adrenal tumours in patients with pathogenic APC mutations: a retrospective study. Hereditary cancer in clinical practice 22 (1) (2024)
Andrzej Hnatyszyn, Marlena Szalata, Aleksandra Zielińska, Karolina Wielgus, Mikołaj Danielewski, Piotr Tomasz Hnatyszyn, Andrzej Pławski, Jarosław Walkowiak, Ryszard Słomski
Mutations in Helicobacter pylori infected patients with chronic gastritis, intestinal type of gastric cancer and familial gastric cancer. Hereditary cancer in clinical practice 22 (1) (2024)
Akihiro Ohmoto, Naomi Hayashi, Shunji Takahashi, Arisa Ueki
Current prospects of hereditary adrenal tumors: towards better clinical management. Hereditary cancer in clinical practice 22 (1) (2024)
Juan Pablo Arango-Ibañez, Luis Gabriel Parra-Lara, Ángela R Zambrano, Lisa Ximena Rodríguez-Rojas
Li-Fraumeni syndrome presenting with de novo TP53 mutation, severe phenotype and advanced paternal age: a case report. Hereditary cancer in clinical practice 22 (1) (2024)
Emil Andersson, Anne Keränen, Kristina Lagerstedt-Robinson, Sam Ghazi, Annika Lindblom, Emma Tham, Miriam Mints
Universal testing in endometrial cancer in Sweden. Hereditary cancer in clinical practice 22 (1) (2024)
Robert F Power, Damien E Doherty, Roberta Horgan, Pat Fahey, David J Gallagher, Maeve A Lowery, Karen A Cadoo
Modifiable risk factors for cancer among people with lynch syndrome: an international, cross-sectional survey. Hereditary cancer in clinical practice 22 (1) (2024)
Andrzej Hnatyszyn, Marlena Szalata, Aleksandra Zielińska, Karolina Wielgus, Mikołaj Danielewski, Piotr Tomasz Hnatyszyn, Andrzej Pławski, Jarosław Walkowiak, Ryszard Słomski
Mutations in Helicobacter pylori infected patients with chronic gastritis, intestinal type of gastric cancer and familial gastric cancer. Hereditary cancer in clinical practice 22 (1) (2024)
Milena Matuszczak, Adam Kiljańczyk, Wojciech Marciniak, Róża Derkacz, Klaudia Stempa, Piotr Baszuk, Marta Bryśkiewicz, Cezary Cybulski, Tadeusz Dębniak, Gronwald Jacek, Tomasz Huzarski, Marcin Lener, Anna Jakubowska, Sandra Pietrzak, Marek Szwiec, Małgorzata Stawicka-Niełacna, Dariusz Godlewski, Artur Prusaczyk, Andrzej Jasiewicz, Tomasz Kluz, Joanna Tomiczek-Szwiec, Ewa Kilar-Kobierzycka, Monika Siołek, Renata Posmyk, Joanna Jarkiewicz-Tretyn, Rodney Scott, Steven Narod, Jan Lubiński
Blood molybdenum level as a marker of cancer risk on BRCA1 carriers. Hereditary cancer in clinical practice 22 (1) (2024)
Akihiro Ohmoto, Naomi Hayashi, Shunji Takahashi, Arisa Ueki
Current prospects of hereditary adrenal tumors: towards better clinical management. Hereditary cancer in clinical practice 22 (1) (2024)
Alexander T Petterson, Jennifer Garbarini, Maria J Baker
Universal screening of colorectal tumors for lynch syndrome: a survey of patient experiences and opinions. Hereditary cancer in clinical practice 22 (1) (2024)
Liwen Yang, Duan Duan, Ying Xiong, Tianjiao Liu, Lijun Zhao, Fan Lai, Dingxian Gu, Liuying Zhou
Preoperative multimodal ultrasonic imaging in a case of Peutz-Jeghers syndrome complicated by atypical lobular endocervical glandular hyperplasia: a case report and literature review. Hereditary cancer in clinical practice 22 (1) (2024)
Lucy Zhao, Lorrie Lynch, Lua Eiriksson
Information needs of Lynch syndrome and BRCA 1/2 mutation carriers considering risk-reducing gynecological surgery: a qualitative study of the decision-making process. Hereditary cancer in clinical practice 22 (1) (2024)
Ivane Javakhishvili, Kote Mardaleishvili, Maka Buleishvili, Maia Mantskava, Irakli Chkhikvishvili, Sophio Kalmakhelidze, Nina Kipiani, Tamar Sanikidze
Possible link between familial susceptibility to cancer and the level of oxidative stress in thyroid cancer patients. Hereditary cancer in clinical practice 22 (1) (2024)
Emil Andersson, Anne Keränen, Kristina Lagerstedt-Robinson, Sam Ghazi, Annika Lindblom, Emma Tham, Miriam Mints
Universal testing in endometrial cancer in Sweden. Hereditary cancer in clinical practice 22 (1) (2024)
P A Skat-Rørdam, Y Kaya, N Qvist, TvO Hansen, T D Jensen, J G Karstensen, A M Jelsig
Gastrointestinal manifestations in patients with gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a systematic review with analysis of individual patient data. Hereditary cancer in clinical practice 22 (1) (2024)
Yingxue Li, Guangqi Li, Zheng Zheng, Wenjuan Wen, Haihui Zhao, Xia Liu, Jiaping Xie, Lin Han
Benefits of osimertinib treat a lung adenocarcinoma patient with germline EGFR T790M, somatic EGFR 19-Del, TP53 and PIK3CA mutations. Hereditary cancer in clinical practice 22 (1) (2024)
Robert F Power, Damien E Doherty, Roberta Horgan, Pat Fahey, David J Gallagher, Maeve A Lowery, Karen A Cadoo
Modifiable risk factors for cancer among people with lynch syndrome: an international, cross-sectional survey. Hereditary cancer in clinical practice 22 (1) (2024)
Yoshimi Kiyozumi, Hiroyuki Matsubayashi, Akiko Todaka, Ryo Ashida, Seiichiro Nishimura, Nobuhiro Kado, Satomi Higashigawa, Rina Harada, Eiko Ishihara, Yasue Horiuchi, Goichi Honda, Hirotsugu Kenmotsu, Masakuni Serizawa, Kenichi Urakami
Two Japanese families with familial pancreatic cancer with suspected pathogenic variants of CDKN2A: a case report. Hereditary cancer in clinical practice 22 (1) (2024)
Annmarie Taheny, Haylie McSwaney, Julia Meade
A second hereditary cancer predisposition syndrome in a patient with lynch syndrome and three primary cancers. Hereditary cancer in clinical practice 22 (1) (2024)
Yoshimi Kiyozumi, Hiroyuki Matsubayashi, Akiko Todaka, Ryo Ashida, Seiichiro Nishimura, Nobuhiro Kado, Satomi Higashigawa, Rina Harada, Eiko Ishihara, Yasue Horiuchi, Goichi Honda, Hirotsugu Kenmotsu, Masakuni Serizawa, Kenichi Urakami
Two Japanese families with familial pancreatic cancer with suspected pathogenic variants of CDKN2A: a case report. Hereditary cancer in clinical practice 22 (1) (2024)
Pål Møller, Saskia Haupt, Aysel Ahadova, Matthias Kloor, Julian R Sampson, Lone Sunde, Toni Seppälä, John Burn, Inge Bernstein, Gabriel Capella, D Gareth Evans, Annika Lindblom, Ingrid Winship, Finlay Macrae, Lior Katz, Ido Laish, Elez Vainer, Kevin Monahan, Elizabeth Half, Karoline Horisberger, Leandro Apolinário da Silva, Vincent Heuveline, Christina Therkildsen, Charlotte Lautrup, Louise L Klarskov, Giulia Martina Cavestro, Gabriela Möslein, Eivind Hovig, Mev Dominguez-Valentin
Incidences of colorectal adenomas and cancers under colonoscopy surveillance suggest an accelerated "Big Bang" pathway to CRC in three of the four Lynch syndromes. Hereditary cancer in clinical practice 22 (1) (2024)
Steven A Narod, Kelly Metcalfe, Amy Finch, An-Wen Chan, Susan Randall Armel, Amber Aeilts, Andrea Eisen, Beth Karlan, Louise Bordeleau, Nadine Tung, William D Foulkes, Susan L Neuhausen, Charis Eng, Olufunmilayo Olopade, Dana Zakalik, Fergus Couch, Carey Cullinane, Tuya Pal, Ping Sun, Joanne Kotsopoulos, null null
The risk of skin cancer in women who carry BRCA1 or BRCA2 mutations. Hereditary cancer in clinical practice 22 (1) (2024)
Yoshimi Kiyozumi, Hiroyuki Matsubayashi, Akiko Todaka, Ryo Ashida, Seiichiro Nishimura, Nobuhiro Kado, Satomi Higashigawa, Rina Harada, Eiko Ishihara, Yasue Horiuchi, Goichi Honda, Hirotsugu Kenmotsu, Masakuni Serizawa, Kenichi Urakami
Two Japanese families with familial pancreatic cancer with suspected pathogenic variants of CDKN2A: a case report. Hereditary cancer in clinical practice 22 (1) (2024)
Pål Møller, Saskia Haupt, Aysel Ahadova, Matthias Kloor, Julian R Sampson, Lone Sunde, Toni Seppälä, John Burn, Inge Bernstein, Gabriel Capella, D Gareth Evans, Annika Lindblom, Ingrid Winship, Finlay Macrae, Lior Katz, Ido Laish, Elez Vainer, Kevin Monahan, Elizabeth Half, Karoline Horisberger, Leandro Apolinário da Silva, Vincent Heuveline, Christina Therkildsen, Charlotte Lautrup, Louise L Klarskov, Giulia Martina Cavestro, Gabriela Möslein, Eivind Hovig, Mev Dominguez-Valentin
Incidences of colorectal adenomas and cancers under colonoscopy surveillance suggest an accelerated "Big Bang" pathway to CRC in three of the four Lynch syndromes. Hereditary cancer in clinical practice 22 (1) (2024)
Robert F Power, Damien E Doherty, Roberta Horgan, Pat Fahey, David J Gallagher, Maeve A Lowery, Karen A Cadoo
Modifiable risk factors for cancer among people with lynch syndrome: an international, cross-sectional survey. Hereditary cancer in clinical practice 22 (1) (2024)
Lyman Lin, Victoria Beshay, Finlay Macrae
Adrenal tumours in patients with pathogenic APC mutations: a retrospective study. Hereditary cancer in clinical practice 22 (1) (2024)
Alexandra Michel, Michel Dorval, Jocelyne Chiquette, Josée Savard
Fear of cancer recurrence in breast cancer survivors carrying a BRCA1 or 2 genetic mutation : a cross-sectional study. Hereditary cancer in clinical practice 22 (1) (2024)
Liwen Yang, Duan Duan, Ying Xiong, Tianjiao Liu, Lijun Zhao, Fan Lai, Dingxian Gu, Liuying Zhou
Preoperative multimodal ultrasonic imaging in a case of Peutz-Jeghers syndrome complicated by atypical lobular endocervical glandular hyperplasia: a case report and literature review. Hereditary cancer in clinical practice 22 (1) (2024)
Akihiro Ohmoto, Naomi Hayashi, Shunji Takahashi, Arisa Ueki
Current prospects of hereditary adrenal tumors: towards better clinical management. Hereditary cancer in clinical practice 22 (1) (2024)
Hua Yuan, Rong Zhang, Ning Li, Hongwen Yao
Primary fallopian tube cancer followed by primary breast cancer in RAD51C mutation carrier treated with niraparib as first line maintenance therapy: a case report. Hereditary cancer in clinical practice 22 (1) (2024)
Lucy Zhao, Lorrie Lynch, Lua Eiriksson
Information needs of Lynch syndrome and BRCA 1/2 mutation carriers considering risk-reducing gynecological surgery: a qualitative study of the decision-making process. Hereditary cancer in clinical practice 22 (1) (2024)
Ivane Javakhishvili, Kote Mardaleishvili, Maka Buleishvili, Maia Mantskava, Irakli Chkhikvishvili, Sophio Kalmakhelidze, Nina Kipiani, Tamar Sanikidze
Possible link between familial susceptibility to cancer and the level of oxidative stress in thyroid cancer patients. Hereditary cancer in clinical practice 22 (1) (2024)
Alexandra Michel, Michel Dorval, Jocelyne Chiquette, Josée Savard
Fear of cancer recurrence in breast cancer survivors carrying a BRCA1 or 2 genetic mutation : a cross-sectional study. Hereditary cancer in clinical practice 22 (1) (2024)
Emil Andersson, Anne Keränen, Kristina Lagerstedt-Robinson, Sam Ghazi, Annika Lindblom, Emma Tham, Miriam Mints
Universal testing in endometrial cancer in Sweden. Hereditary cancer in clinical practice 22 (1) (2024)
Alexandra Michel, Michel Dorval, Jocelyne Chiquette, Josée Savard
Fear of cancer recurrence in breast cancer survivors carrying a BRCA1 or 2 genetic mutation : a cross-sectional study. Hereditary cancer in clinical practice 22 (1) (2024)
Yingxue Li, Guangqi Li, Zheng Zheng, Wenjuan Wen, Haihui Zhao, Xia Liu, Jiaping Xie, Lin Han
Benefits of osimertinib treat a lung adenocarcinoma patient with germline EGFR T790M, somatic EGFR 19-Del, TP53 and PIK3CA mutations. Hereditary cancer in clinical practice 22 (1) (2024)
P A Skat-Rørdam, Y Kaya, N Qvist, TvO Hansen, T D Jensen, J G Karstensen, A M Jelsig
Gastrointestinal manifestations in patients with gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a systematic review with analysis of individual patient data. Hereditary cancer in clinical practice 22 (1) (2024)
Annmarie Taheny, Haylie McSwaney, Julia Meade
A second hereditary cancer predisposition syndrome in a patient with lynch syndrome and three primary cancers. Hereditary cancer in clinical practice 22 (1) (2024)
Steven A Narod, Kelly Metcalfe, Amy Finch, An-Wen Chan, Susan Randall Armel, Amber Aeilts, Andrea Eisen, Beth Karlan, Louise Bordeleau, Nadine Tung, William D Foulkes, Susan L Neuhausen, Charis Eng, Olufunmilayo Olopade, Dana Zakalik, Fergus Couch, Carey Cullinane, Tuya Pal, Ping Sun, Joanne Kotsopoulos, null null
The risk of skin cancer in women who carry BRCA1 or BRCA2 mutations. Hereditary cancer in clinical practice 22 (1) (2024)
Lucy Zhao, Lorrie Lynch, Lua Eiriksson
Information needs of Lynch syndrome and BRCA 1/2 mutation carriers considering risk-reducing gynecological surgery: a qualitative study of the decision-making process. Hereditary cancer in clinical practice 22 (1) (2024)

volume 21, number 1, 2023

Sergio Carrera, Ana Belén Rodríguez-Martínez, Intza Garin, Esther Sarasola, Cristina Martínez, Hiart Maortua, Almudena Callejo, Abigail Ruiz de Lobera, Alberto Muñoz, Nagore Miñambres, Pablo Jiménez-Labaig
Germline heterozygous exons 8-11 pathogenic BARD1 gene deletion reported for the first time in a family with suspicion of a hereditary colorectal cancer syndrome: more than an incidental finding? Hereditary cancer in clinical practice 21 (1) (2023)
Kari Hemminki, Xinjun Li, Asta Försti, Charis Eng
Are population level familial risks and germline genetics meeting each other? Hereditary cancer in clinical practice 21 (1) (2023)
Sergio Carrera, Ana Belén Rodríguez-Martínez, Intza Garin, Esther Sarasola, Cristina Martínez, Hiart Maortua, Almudena Callejo, Abigail Ruiz de Lobera, Alberto Muñoz, Nagore Miñambres, Pablo Jiménez-Labaig
Germline heterozygous exons 8-11 pathogenic BARD1 gene deletion reported for the first time in a family with suspicion of a hereditary colorectal cancer syndrome: more than an incidental finding? Hereditary cancer in clinical practice 21 (1) (2023)
Sergio Carrera, Ana Belén Rodríguez-Martínez, Intza Garin, Esther Sarasola, Cristina Martínez, Hiart Maortua, Almudena Callejo, Abigail Ruiz de Lobera, Alberto Muñoz, Nagore Miñambres, Pablo Jiménez-Labaig
Germline heterozygous exons 8-11 pathogenic BARD1 gene deletion reported for the first time in a family with suspicion of a hereditary colorectal cancer syndrome: more than an incidental finding? Hereditary cancer in clinical practice 21 (1) (2023)
Kari Hemminki, Xinjun Li, Asta Försti, Charis Eng
Are population level familial risks and germline genetics meeting each other? Hereditary cancer in clinical practice 21 (1) (2023)
Olfat Ahmad, Asta Försti
The complementary roles of genome-wide approaches in identifying genes linked to an inherited risk of colorectal cancer. Hereditary cancer in clinical practice 21 (1) (2023)
Olfat Ahmad, Asta Försti
The complementary roles of genome-wide approaches in identifying genes linked to an inherited risk of colorectal cancer. Hereditary cancer in clinical practice 21 (1) (2023)